Related Experiment Video
Updated: May 18, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Aberrant microRNA expression and its implications in the pathogenesis of leukemias
Sadegh Babashah1, Majid Sadeghizadeh, Mostafa Rezaei Tavirani
1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, 1411713116, Tehran, Iran. sadegh.babashah@gmail.com
Background:
MicroRNAs (miRNAs) are a class of non-coding, endogenous, small RNAs that negatively regulate gene expression by inducing degradation or translational inhibition of target mRNAs. Aberrant expression of miRNAs appears to be a common characteristic of hematological malignancies including leukemias.
Aim:
Here we review the available data supporting a role of aberrant expression of miRNAs in the pathogenesis of leukemias including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL).
Conclusions:
The expression signatures of miRNAs provide exciting opportunities in the diagnosis, prognosis, and therapy of leukemia. Since miRNAs can function as either oncogenes or tumor suppressor genes in leukemogenesis, the potential of using these small RNAs as therapeutic targets opens up new opportunities for leukemia therapy by either inhibiting or augmenting their activity.
Insights
MicroRNAs (miRNAs) are small RNAs crucial in gene regulation. Aberrant miRNA expression is linked to leukemia, offering new diagnostic and therapeutic strategies for blood cancers.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression.
- Dysregulated miRNA expression is a hallmark of hematological malignancies, particularly leukemias.
Purpose of the Study:
- To review current data on the role of aberrant miRNA expression in leukemia pathogenesis.
- To cover various leukemia types including AML, ALL, CML, and CLL.
Main Methods:
- Literature review of studies investigating miRNA expression in leukemias.
- Analysis of miRNA roles in the molecular mechanisms of leukemogenesis.
Main Results:
- Evidence supports a significant role for altered miRNA expression in the development of different leukemia subtypes.
- miRNAs can act as oncogenes or tumor suppressors in leukemic cells.
Conclusions:
- miRNA expression profiles offer potential for improved leukemia diagnosis and prognosis.
- Targeting miRNAs presents novel therapeutic avenues for leukemia treatment, either by inhibition or augmentation.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...

